Lv3
280 积分 2025-10-22 加入
Claudin 18.2 as a novel therapeutic target
2天前
已完结
Towards biomarker-based diagnosis of Parkinson disease
1个月前
已完结
From technological iteration to clinical breakthrough: advances of CAR-T cell therapy in autoimmune diseases
3个月前
已完结
Targeting Prostatic Acid Phosphatase in Prostate Cancer: Roadmap on How To Venture Above and Beyond Prostate-specific Membrane Antigen with ACP3 Theranostics
3个月前
已关闭
Detectability of Al18F-NOTA-HER2-BCH PET for Nodal Metastases in Patients With HER2-Positive Breast Cancer
3个月前
已完结
Al18F-NOTA-HER2-BCH Versus 18F-FDG PET/CT for Detecting Bone Metastases
3个月前
已完结
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program
3个月前
已完结
Targeting Prostatic Acid Phosphatase in Prostate Cancer: Roadmap on How To Venture Above and Beyond Prostate-specific Membrane Antigen with ACP3 Theranostics
3个月前
已关闭
Discovery of high-affinity ligands for prostatic acid phosphatase via DNA-encoded library screening enables targeted cancer therapy
3个月前
已完结
Targeting Prostatic Acid Phosphatase in Prostate Cancer: Roadmap on How To Venture Above and Beyond Prostate-specific Membrane Antigen with ACP3 Theranostics
3个月前
已关闭
皖公网安备34019202002308
